|Authors||Zarebczan B, Chen H|
|Journal||Endocrinol. Metab. Clin. North Am. Volume: 39 Issue: 4 Pages: 801-10|
|Publish Date||2010 Dec|
Although neuroendocrine tumors are rare, the more common types such as gastrointestinal and pancreatic carcinoids, medullary thyroid cancers, and small cell lung cancers have been studied in detail during the last few years. Data published thus far indicate that multiple signaling pathways are involved in these cancers. Recent focus has been on developing novel therapeutics by targeting specific signaling pathways. This article details several of the signaling mechanisms that have been discovered to play a role in the development and progression of neuroendocrine tumors. The therapeutic options developed to address the various pathways, including their specific mechanisms of actions, are also discussed.
|Full Text||Full text available on PubMed Central|